Antivirals for Virus Induced Exacerbations of Asthma and COPD Treatment-Reference-Cited by-同舟云学术

Antivirals for Virus Induced Exacerbations of Asthma and COPD Treatment

Published:2018-11-01 Issue:3 Volume:24 Page:152-156
ISSN:1841-4036
Container-title:ARS Medica Tomitana
language:en
Short-container-title:

Author:

Cristina Grigorescu¹,Antonela Antoniu Sabina¹,Ruxandra Oţelea Marina²,Antohe Ileana¹,Petronela Fildan Ariadna³,Anton Arghir Ioan³,Doina Tofolean Ecaterina³

Affiliation:

1. University of Medicine and Pharmacy “Gr. T. Popa”, Iasi , Romania

2. University of Medicine and Pharmacy “Carol Davila” , Bucharest , Romania

3. Faculty of Medicine , University “Ovidius” of Constanta , Romania

Abstract

Abstract Viral respiratory infections in patients with asthma or chronic obstructive pulmonary disease (COPD) can cause severe exacerbations, increasing the risk of secondary bacterial infections and having a significant impact on disease-related morbidity and mortality. Several antivirals such as oseltamivir and zanamivir evaluated in influenza and other virus-induced respiratory infections are discussed in this review as a starting point of their potential use in improving the outcome of asthma and COPD exacerbations. However, the efficacy of antiviral therapy for asthma/COPD exacerbations needs a further evaluation.

Publisher

Walter de Gruyter GmbH

Subject

General Biochemistry, Genetics and Molecular Biology

Link

https://www.sciendo.com/pdf/10.2478/arsm-2018-0027

Reference35 articles.

1. 1. Mihailov C, Jimborean G, Rascu A, Arghir, OC. The Impact of Tobacco Smoke Exposure on Asthma COPD-Like Patients. J. Environ. Prot. Ecol. 2016;17(4), 1523-1523.

2. 2. Dantes E, Man MA, Arghir OA, Alexandrescu D, Trofor A. Risk factors and overlap between asthma and chronic obstructive pulmonary disease. Proceedings of the International Conference on Risk Management, Assessment and Mitigation, RIMA ‘10; WSEAS Conference Book „RECENT ADVANCES IN RISK MANAGEMENT, ASSESSMENT AND MITIGATION” Australia WSEAS Press. 2010;369-373.

3. 3. Rascu A, Popa DE, Arghir OC, Naghi E. Effects of Corticosteroid Treatment on Respiratory Muscles Function in Patients with Severe Obstructive Lung Disease, FARMACIA. 2016; 64(6):819-822.

4. 4. Biancardi E, Fennell M, Rawlinson W, Thomas PS. Viruses are frequently present as the infecting agent in acute exacerbations of chronic obstructive pulmonary disease in patients presenting to hospital. Int. Med. J. 2016;46, 1160-1165.

5. 5. Mohan A, Chandra S, Agarwal D, Guleria R, Broor S, Gaur B, Pandey RM. Prevalence of viral infection detected by PCR and RTPCR in patients with acute exacerbation of COPD: a systematic review. Respirology. 2010;15, 536-542.